Unusual bone metastasis from follicular carcinoma thyroid: presenting as a primary bone malignancy

Saurabh Varshney, Harish Chandra Pant


Osseous metastasis in patients of thyroid carcinoma is not very common, and appendicular skeleton is very rare. Bone metastasis represents a complication, especially of follicular thyroid carcinoma and severely reduces the quality of life causing pain, and fractures. Diagnosis is typically done by correlating clinical suspicion with imaging. Occult clinical presentations usually delay the detection and management of patients with bone metastasis from thyroid carcinoma. There is limited information about the clinical presentations and prognosis of patients with follicular thyroid carcinoma with bone metastasis. We hereby present a case report of right arm swelling diagnosed as metastatic carcinoma having metastasis from thyroid primary.


Follicular Carcinoma; Thyroid; Skeleton Metastasis

Full Text:



McCormack KR. Bone metastases from thyroid carcinoma. Cancer 1966; 19:181-4.

Marcocci C, Pacini F, Elisei R, et al. Clinical and biologic behaviour of bone metastases from differentiated thyroid carcinoma. Surgery 1989; 106:960-6.

Galasko CSB. Detection of Skeletal Metastasis. J Bone Joint Surgery 1971; 53-B: 153.

Greenspan A, Norman A. Osteolytic cortical destruction: an unusual pattern of skeletal metastases. Skeletal Radiol 1988; 17:402-6.

Jacobsen S, Stephensen SL, Paaske BP, et al. Skeletal metastases of unknown origin: a retrospective analysis of 29 cases. Acta Orthop Belg 1997; 63:15-22.

Soderlund V. Radiological Diagnosis of Skeletal Metastases. Eur Radiol 1996; 6: 587-95.

Muresan MM, Olivier P, Leclère J, et al. Bone metastases from differentiated thyroid carcinoma. Endocr Relat Cancer 2008; 15:37-49.

Wood WJ Jr, Singletary SE, Hickey RC. Current results of treatment for distant metastatic well-differentiated thyroid carcinoma. Arch Surg 1989; 124:1374-7.

DOI: http://dx.doi.org/10.14319/ijcto.0204.11

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.


International Journal of Cancer Therapy and Oncology (ISSN 2330-4049)

© International Journal of Cancer Therapy and Oncology (IJCTO)

To make sure that you can receive messages from us, please add the 'ijcto.org' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.


Number of visits since October, 2013